
Haejin S. Park
Examiner (ID: 2263, Phone: (571)270-5258 , Office: P/1615 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1614, 1611, 1615 |
| Total Applications | 830 |
| Issued Applications | 412 |
| Pending Applications | 109 |
| Abandoned Applications | 336 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14649169
[patent_doc_number] => 20190231713
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-01
[patent_title] => METHODS FOR TREATING OR PREVENTING ORGANOPHOSPHATE POISONING
[patent_app_type] => utility
[patent_app_number] => 16/333685
[patent_app_country] => US
[patent_app_date] => 2017-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6729
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16333685
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/333685 | Methods for treating or preventing organophosphate poisoning | Sep 17, 2017 | Issued |
Array
(
[id] => 16703215
[patent_doc_number] => 10953130
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-23
[patent_title] => Solid hemostatic composition and methods of making the same
[patent_app_type] => utility
[patent_app_number] => 15/692654
[patent_app_country] => US
[patent_app_date] => 2017-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6160
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15692654
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/692654 | Solid hemostatic composition and methods of making the same | Aug 30, 2017 | Issued |
Array
(
[id] => 12091131
[patent_doc_number] => 20170348224
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-07
[patent_title] => 'CHEMICALLY STABLE COMPOSITIONS OF A PHARMACEUTICAL ACTIVE AGENT IN A MULTI-CHAMBERED DELIVERY SYSTEM FOR MUCOSAL DELIVERY'
[patent_app_type] => utility
[patent_app_number] => 15/682764
[patent_app_country] => US
[patent_app_date] => 2017-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 26605
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15682764
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/682764 | Chemically stable compositions of a pharmaceutical active agent in a multi- chambered delivery system for mucosal delivery | Aug 21, 2017 | Issued |
Array
(
[id] => 14892163
[patent_doc_number] => 20190289847
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-26
[patent_title] => SUSTAINED RELEASE FIBERS
[patent_app_type] => utility
[patent_app_number] => 16/334626
[patent_app_country] => US
[patent_app_date] => 2017-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6177
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -47
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16334626
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/334626 | SUSTAINED RELEASE FIBERS | Aug 8, 2017 | Abandoned |
Array
(
[id] => 17080429
[patent_doc_number] => 20210275435
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => COMPOSITION FOR INHIBITING SEBUM SECRETION COMPRISING PEACH SPROUT EXTRACT
[patent_app_type] => utility
[patent_app_number] => 16/321782
[patent_app_country] => US
[patent_app_date] => 2017-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4757
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16321782
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/321782 | Composition for inhibiting sebum secretion comprising peach sprout extract | Jul 24, 2017 | Issued |
Array
(
[id] => 12029371
[patent_doc_number] => 20170319470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-09
[patent_title] => 'METHODS OF MANUFACTURING VISCOUS LIQUID PHARMACEUTICAL FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 15/658965
[patent_app_country] => US
[patent_app_date] => 2017-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 15008
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15658965
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/658965 | METHODS OF MANUFACTURING VISCOUS LIQUID PHARMACEUTICAL FORMULATIONS | Jul 24, 2017 | Abandoned |
Array
(
[id] => 17936950
[patent_doc_number] => 11471382
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-18
[patent_title] => Emulsion with matte effects and excellent texture
[patent_app_type] => utility
[patent_app_number] => 16/302905
[patent_app_country] => US
[patent_app_date] => 2017-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18208
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16302905
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/302905 | Emulsion with matte effects and excellent texture | Jul 17, 2017 | Issued |
Array
(
[id] => 12023709
[patent_doc_number] => 20170313808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-02
[patent_title] => 'BIOACTIVE POLYMERIC LIQUID FORMULATIONS OF ABSORBABLE, SEGMENTED APLIPHATIC POLYURETHANE COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/652135
[patent_app_country] => US
[patent_app_date] => 2017-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7826
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15652135
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/652135 | BIOACTIVE POLYMERIC LIQUID FORMULATIONS OF ABSORBABLE, SEGMENTED APLIPHATIC POLYURETHANE COMPOSITIONS | Jul 16, 2017 | Abandoned |
Array
(
[id] => 12125016
[patent_doc_number] => 20180008603
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-11
[patent_title] => 'PHARMACEUTICAL COMPOSITION CONTAINING CRYSTALLINE MACITENTAN'
[patent_app_type] => utility
[patent_app_number] => 15/645015
[patent_app_country] => US
[patent_app_date] => 2017-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7694
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15645015
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/645015 | PHARMACEUTICAL COMPOSITION CONTAINING CRYSTALLINE MACITENTAN | Jul 9, 2017 | Abandoned |
Array
(
[id] => 15678175
[patent_doc_number] => 20200093751
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-26
[patent_title] => CHEMOPROTECTIVE/CHEMOACTIVE NANODROPLETS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/313929
[patent_app_country] => US
[patent_app_date] => 2017-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8270
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -46
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16313929
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/313929 | CHEMOPROTECTIVE/CHEMOACTIVE NANODROPLETS AND METHODS OF USE THEREOF | Jun 26, 2017 | Abandoned |
Array
(
[id] => 16640761
[patent_doc_number] => 10918582
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-16
[patent_title] => Liquid mixture containing 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one, a niacinamide compound, and cosmetic composition containing same
[patent_app_type] => utility
[patent_app_number] => 16/311906
[patent_app_country] => US
[patent_app_date] => 2017-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1675
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16311906
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/311906 | Liquid mixture containing 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one, a niacinamide compound, and cosmetic composition containing same | Jun 22, 2017 | Issued |
Array
(
[id] => 16498913
[patent_doc_number] => 10864280
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-15
[patent_title] => Nanodroplet compositions for the efficient delivery of anti-cancer agents
[patent_app_type] => utility
[patent_app_number] => 16/308115
[patent_app_country] => US
[patent_app_date] => 2017-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 10369
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 175
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16308115
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/308115 | Nanodroplet compositions for the efficient delivery of anti-cancer agents | Jun 8, 2017 | Issued |
Array
(
[id] => 11954620
[patent_doc_number] => 20170258768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-14
[patent_title] => 'ONDANSETRON EXTENDED RELEASE SOLID DOSAGE FORMS FOR TREATING EITHER NAUSEA, VOMITING OR DIARRHEA SYMPTOMS'
[patent_app_type] => utility
[patent_app_number] => 15/606650
[patent_app_country] => US
[patent_app_date] => 2017-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 34022
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15606650
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/606650 | Compositions, methods and kits for treating diarrhea-predominant irritable bowel syndrome | May 25, 2017 | Issued |
Array
(
[id] => 11942089
[patent_doc_number] => 20170246239
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-31
[patent_title] => 'ANTI-BLEPHARITIS COMPOSITIONS AND THEIR USE'
[patent_app_type] => utility
[patent_app_number] => 15/597028
[patent_app_country] => US
[patent_app_date] => 2017-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4906
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15597028
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/597028 | ANTI-BLEPHARITIS COMPOSITIONS AND THEIR USE | May 15, 2017 | Abandoned |
Array
(
[id] => 17741512
[patent_doc_number] => 11389559
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-19
[patent_title] => Wound dressing or dermal patch
[patent_app_type] => utility
[patent_app_number] => 16/302415
[patent_app_country] => US
[patent_app_date] => 2017-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7338
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 195
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16302415
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/302415 | Wound dressing or dermal patch | May 14, 2017 | Issued |
Array
(
[id] => 11935171
[patent_doc_number] => 20170239319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-24
[patent_title] => 'ANTI-BLEPHARITIS COMPOSITIONS AND THEIR USE'
[patent_app_type] => utility
[patent_app_number] => 15/589293
[patent_app_country] => US
[patent_app_date] => 2017-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4889
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15589293
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/589293 | ANTI-BLEPHARITIS COMPOSITIONS AND THEIR USE | May 7, 2017 | Abandoned |
Array
(
[id] => 11935169
[patent_doc_number] => 20170239317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-24
[patent_title] => 'ANTI-BLEPHARITIS COMPOSITIONS AND THEIR USE'
[patent_app_type] => utility
[patent_app_number] => 15/589271
[patent_app_country] => US
[patent_app_date] => 2017-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4979
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15589271
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/589271 | ANTI-BLEPHARITIS COMPOSITIONS AND THEIR USE | May 7, 2017 | Abandoned |
Array
(
[id] => 11977397
[patent_doc_number] => 20170281551
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-05
[patent_title] => 'SOLID PHARMACEUTICAL COMPOSITIONS AND PROCESSES FOR THEIR PRODUCTION'
[patent_app_type] => utility
[patent_app_number] => 15/496728
[patent_app_country] => US
[patent_app_date] => 2017-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14001
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15496728
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/496728 | SOLID PHARMACEUTICAL COMPOSITIONS AND PROCESSES FOR THEIR PRODUCTION | Apr 24, 2017 | Abandoned |
Array
(
[id] => 11850651
[patent_doc_number] => 20170225143
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-10
[patent_title] => 'METHODS AND COMPOSITIONS FOR PRODUCING HYDROGEL CAPSULES COATED FOR LOW PERMEABILITY AND PHYSICAL INTEGRITY'
[patent_app_type] => utility
[patent_app_number] => 15/493745
[patent_app_country] => US
[patent_app_date] => 2017-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 10088
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15493745
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/493745 | METHODS AND COMPOSITIONS FOR PRODUCING HYDROGEL CAPSULES COATED FOR LOW PERMEABILITY AND PHYSICAL INTEGRITY | Apr 20, 2017 | Abandoned |
Array
(
[id] => 11755917
[patent_doc_number] => 20170202784
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-20
[patent_title] => 'CONFIGURABLE CLATHRIN LIGHT CHAIN COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 15/472525
[patent_app_country] => US
[patent_app_date] => 2017-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 33822
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15472525
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/472525 | CONFIGURABLE CLATHRIN LIGHT CHAIN COMPOSITION | Mar 28, 2017 | Abandoned |